Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Hepatology

Biology & Transmission: How Hepatitis Delta Works

At a Glance

Hepatitis Delta (HDV) is a unique virus that requires the Hepatitis B virus to survive. It spreads through blood and sexual contact. HDV can suppress Hepatitis B, making it look like your liver disease is inactive, so specific HDV testing is crucial if your liver enzymes are high.

While most viruses carry their own tools to survive and spread, Hepatitis Delta (HDV) is a “defective” virus that survives by borrowing what it needs from its host, the Hepatitis B virus (HBV) [1][2]. Understanding this relationship helps explain why HDV only affects people who also have HBV and how modern treatments are designed to stop it.

The Lock and Key: How HDV Enters the Liver

To enter a liver cell (hepatocyte), the virus must find a specific “doorway.” This doorway is a protein on the surface of your liver cells called the NTCP receptor [3].

Normally, the NTCP receptor helps your liver transport bile acids [4]. However, HBV and HDV use this receptor as a lock and key. The virus carries a special “key” that fits perfectly into the NTCP “lock,” allowing it to enter and start reproducing [5][6].

  • Treatment Connection: Some of the newest treatments for HDV, called entry inhibitors, work by “plugging” the NTCP lock so the virus cannot get inside the cell to cause damage [4][7].

The Borrowed “Shell”: Packaging and Release

Once inside, HDV can copy its genetic material, but it cannot leave the cell to infect others on its own [8]. It needs a container. It steals the Hepatitis B surface antigen (HBsAg)—the outer shell produced by the Hepatitis B virus—and wraps itself in it [2][9].

This process requires a specific chemical change called prenylation, where a host enzyme (farnesyltransferase) acts like a glue to help the HDV core stick to its borrowed shell [7][10].

  • Treatment Connection: Researchers are developing drugs called farnesyltransferase inhibitors that prevent this “gluing” process, effectively trapping the virus inside the cell so it cannot spread further [7][11].

HDV Genotypes: Does Your Type Matter?

There are 8 distinct “versions” of HDV, known as genotypes [12]. These genotypes are often tied to specific parts of the world:

  • Genotype 1: The most common worldwide, found across Europe, Asia, and Africa [13].
  • Genotype 2 & 4: Primarily seen in East Asia (such as Japan and Taiwan) [14].
  • Genotype 3: Mostly found in the Amazon Basin of South America and is often associated with more severe, sudden liver failure [14].
  • Genotypes 5-8: Mostly found in Africa [14].

Your genotype can influence how your disease progresses and how well you might respond to certain medications [15]. For example, studies suggest Genotype 5 may have a slightly milder course compared to Genotype 1 [15][16].

How HDV is Transmitted

Because HDV travels inside an HBV shell, it is transmitted in the exact same ways as Hepatitis B [1][17]. The virus moves through:

  • Blood-to-blood contact: Sharing needles, razors, or medical equipment that hasn’t been properly sterilized [1][18].
  • Sexual contact: The virus can be passed through intimate contact [1].
  • Perinatal transmission: A mother can pass the virus to her baby during childbirth, though this is less common than blood-borne routes [1].

What Else Could It Be? (Viral Interference & Misdiagnosis)

Because HDV causes spikes in liver enzymes, it is sometimes mistaken for other conditions, such as an acute HBV flare, autoimmune hepatitis, or drug-induced liver injury [1][19].

However, the biggest diagnostic pitfall involves how HDV and HBV interact. In a phenomenon called viral interference, the HDV virus itself often suppresses the Hepatitis B virus [20]. This means your HBV DNA viral load might look very low or even undetectable, tricking doctors into thinking your liver disease is inactive [21]. If you have low HBV DNA but elevated liver enzymes, specialized HDV testing (looking for HDV RNA) is absolutely essential [22]. Never stop taking your HBV medications to “unmask” the virus; always follow your specialist’s guidance.

Common questions in this guide

Why do I need to have Hepatitis B to get Hepatitis Delta?
Hepatitis Delta is a "defective" virus that cannot reproduce or spread on its own. It needs to borrow the outer shell of the Hepatitis B virus to package its genetic material and infect other liver cells.
How is Hepatitis Delta (HDV) transmitted?
HDV is transmitted through blood-to-blood contact, sexual contact, and occasionally from mother to baby during childbirth. Because HDV requires the Hepatitis B virus to survive, it spreads in the exact same ways as Hepatitis B.
What does an HDV genotype mean?
A genotype is a specific strain or version of the Hepatitis Delta virus. There are eight different HDV genotypes globally, which can influence how severe your liver disease becomes and how well you respond to treatment.
Why might my doctor miss an HDV diagnosis if my Hepatitis B is inactive?
Hepatitis Delta often suppresses the Hepatitis B virus in a process called viral interference. This can cause your Hepatitis B viral load to look very low or undetectable, tricking doctors into thinking your liver disease is inactive despite elevated liver enzymes.
How do new treatments stop Hepatitis Delta from entering liver cells?
To infect a liver cell, HDV must attach to a specific doorway called the NTCP receptor. Newer medications known as entry inhibitors work by plugging this receptor, preventing the virus from getting inside the cell to cause further damage.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my HDV genotype, and how does it affect my expected clinical course or response to therapy?
  2. 2.How does the NTCP receptor relate to my current treatment options? Is an entry inhibitor like Bulevirtide right for me?
  3. 3.Since HDV is blood-borne, what specific precautions should I take to protect my family or sexual partners?
  4. 4.Could my previous lab results have missed HDV because my low HBV DNA made it look like my liver disease was inactive?
  5. 5.If I have a sudden 'flare' of liver enzymes, how will you distinguish between an HDV super-infection and an HBV flare or drug-induced injury?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.

    Usai C, Gill US, Riddell AC, et al.

    Alimentary pharmacology & therapeutics 2022; (55(8)):978-993 doi:10.1111/apt.16807.

    PMID: 35292991
  2. 2

    Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.

    Wang W, Lempp FA, Schlund F, et al.

    Journal of hepatology 2021; (75(2)):311-323 doi:10.1016/j.jhep.2021.03.025.

    PMID: 33845061
  3. 3

    Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.

    Giersch K, Hermanussen L, Volz T, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2021; (41(2)):410-419 doi:10.1111/liv.14677.

    PMID: 32997847
  4. 4

    Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.

    Jachs M, Schwarz C, Panzer M, et al.

    Alimentary pharmacology & therapeutics 2022; (56(1)):144-154 doi:10.1111/apt.16945.

    PMID: 35514008
  5. 5

    [Solute carrier NTCP, a key actor in liver infections by hepatitis viruses and a promising antiviral target].

    Verrier ER, Heydmann L, Baumert TF, Schuster C

    Virologie (Montrouge, France) 2018; (22(1)):55-66 doi:10.1684/vir.2018.0716.

    PMID: 33111669
  6. 6

    Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.

    Watashi K, Wakita T

    Cold Spring Harbor perspectives in medicine 2015; (5(8)):a021378.

    PMID: 26238794
  7. 7

    Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfection.

    Brancaccio G, Gaeta GB

    International journal of antimicrobial agents 2019; (54(6)):697-701 doi:10.1016/j.ijantimicag.2019.09.012.

    PMID: 31541699
  8. 8

    Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets.

    Zi J, Gao X, Du J, et al.

    Frontiers in microbiology 2022; (13()):838382 doi:10.3389/fmicb.2022.838382.

    PMID: 35464929
  9. 9

    Hepatitis D Virus Replication.

    Taylor JM

    Cold Spring Harbor perspectives in medicine 2015; (5(11)).

    PMID: 26525452
  10. 10

    Emerging drugs for hepatitis D.

    Keskin O, Yurdaydin C

    Expert opinion on emerging drugs 2023; (28(2)):55-66 doi:10.1080/14728214.2023.2205639.

    PMID: 37096555
  11. 11

    Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

    Lempp FA, Ni Y, Urban S

    Nature reviews. Gastroenterology & hepatology 2016; (13(10)):580-9 doi:10.1038/nrgastro.2016.126.

    PMID: 27534692
  12. 12

    Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania.

    Grecu LI, Pavel-Tanasa M, Matei L, et al.

    Pathogens (Basel, Switzerland) 2024; (13(9)) doi:10.3390/pathogens13090793.

    PMID: 39338984
  13. 13

    Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand.

    Ananchuensook P, Suksawatamnuay S, Thaimai P, et al.

    Scientific reports 2023; (13(1)):22633 doi:10.1038/s41598-023-49819-2.

    PMID: 38114689
  14. 14

    Endemicity and genetic diversity of Hepatitis delta virus among Pygmies in Cameroon, Central Africa.

    Foupouapouognigni Y, Mfonkou JDT, Boyomo O, et al.

    BMC research notes 2022; (15(1)):87 doi:10.1186/s13104-022-05976-7.

    PMID: 35241131
  15. 15

    Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.

    Spaan M, Carey I, Bruce M, et al.

    Journal of hepatology 2020; (72(6)):1097-1104 doi:10.1016/j.jhep.2019.12.028.

    PMID: 31981726
  16. 16

    Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.

    Roulot D, Brichler S, Layese R, et al.

    Journal of hepatology 2020; (73(5)):1046-1062 doi:10.1016/j.jhep.2020.06.038.

    PMID: 32634548
  17. 17

    The genetic landscape of hepatitis delta virus infection.

    Bigogno CM, Falahieh RR, Ho KMA, et al.

    Clinical medicine (London, England) 2020; (20(Suppl 2)):s101 doi:10.7861/clinmed.20-2-s101.

    PMID: 32409407
  18. 18

    Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options.

    Alfaiate D, Dény P, Durantel D

    Antiviral research 2015; (122()):112-29.

    PMID: 26275800
  19. 19

    Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era.

    Kushner T, Da BL, Chan A, et al.

    Transplantation direct 2022; (8(1)):e1253 doi:10.1097/TXD.0000000000001253.

    PMID: 34957333
  20. 20

    Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg.

    Shekhtman L, Cotler SJ, Hershkovich L, et al.

    Scientific reports 2020; (10(1)):7837 doi:10.1038/s41598-020-64122-0.

    PMID: 32398799
  21. 21

    Adenine Base Editing Potently Suppresses Hepatitis B Surface Antigen Expression and Inhibits Hepatitis D Virus Release.

    Kumar A, Combe E, Smekalova EM, et al.

    bioRxiv : the preprint server for biology 2026; doi:10.64898/2026.02.06.704371.

    PMID: 41676540
  22. 22

    A Review of HDV Infection.

    Caviglia GP, Ciancio A, Rizzetto M

    Viruses 2022; (14(8)) doi:10.3390/v14081749.

    PMID: 36016371

This page provides educational information about Hepatitis Delta biology and transmission. It is not medical advice; always discuss your specific HDV diagnosis, symptoms, and testing with a hepatologist.

Get notified when new evidence is published on Hepatitis delta.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.